Description
KP-102 research peptide
KP-102 is the development code for pralmorelin (GHRP-2), a synthetic hexapeptide ghrelin-receptor agonist.
Product details
| Compound | KP-102 (pralmorelin, GHRP-2) |
|---|---|
| Class | Growth hormone-releasing peptide (hexapeptide) |
| Form | Peptide; Nasal Spray; Sublingual Tablets |
| Strength | 5mg; 10mg; 100mcg per spray/10mg; 500mcg per tablet/20ct/10mg; 500mcg per tablet/40ct/20mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What KP-102 research has examined
- Ghrelin receptor signalling: GH release.
- Endocrine research: cortisol and prolactin responses.
- Diagnostic research: tests of GH reserve.
Research interest does not establish a proven effect in humans.
Regulatory status
KP-102 is not an approved medicine. Growth hormone secretagogues and related peptides are prohibited in sport by WADA, and the material sold here is a research chemical only.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Reduced Glutathione · PTD-DBM · Liraglutide · All unreconstituted peptides
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.